オンコサーキアシス,ロアシス,マンソネルロシスのランダム化臨床試験の設計と分析:体系的なレビュー
Fabrice Lotola Mougeni1, Marta Bofill Roig2, Marc P Hübner3,4
1Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
PLoS neglected tropical diseases
|February 20, 2026
まとめ
このレビューは,フィラリア疾患試験における統計的課題を強調し,設計と分析の有意な異質性を発見しました. CONSORTおよびICH E9 (R1) ガイドラインを用いた報告の改善は,オンコサーキアシス,ロアシス,マンソネルシスの研究の透明性のために推奨されます.
科学分野:
- 臨床試験の方法論 臨床試験の方法論
- 寄生虫による病気
- バイオ統計学 バイオ統計学
背景:
- オンコサーキアシス,ロアシス,マンソネルロシスなどのフィラリア性疾患に関するランダム化臨床試験 (RCT) は,統計上の障害に直面しています.
- 課題には,歪んだエンドポイントと小さなサンプルサイズがあり,試験の設計と分析を複雑にします.
研究 の 目的:
- オンコサーキアシス,ロエアシス,マンソネルロシスに関するRCTの設計と統計分析方法を体系的に検討する.
- これらの見捨てられた熱帯病に対する試験方法論の改善のための共通の実践と分野を特定する.
主な方法:
- 関連するRCTのためのPubMedと試験登録簿 (2000-2024) の系統的な検索.
- 含有/除外基準は,初期段階または薬理学動力学的試験を除く治療試験に焦点を当てました.
- 44の適格な研究のための手稿,プロトコル,およびレジストリからのデータ抽出.
主要な成果:
- オンコサーキアシス試験では,主に質的プライマリエンドポイントが使用され,ロアシスとマンソネルロシス試験では,より頻繁に定量的なエンドポイントが使用されました.
- マン・ウィトニーUとチ2テストは,プライマリエンドポイント分析において一般的であった.
- 試験の設計パラメータ (エンドポイント,フォローアップ,分析集団) において,研究全体で顕著な異質性が見られた.
結論:
- いくつかの試験は報告が十分であったが,他の試験では十分な詳細が欠け,より構造的で透明な報告が必要になった.
- CONSORTとICH E9 (R1) の見積もり方法の採用が推奨されています.
- 透明性の向上により,フィラリア疾患の研究における試験目標,分析,結論がよりよく整合される.
関連する概念動画
Study Designs in Epidemiology
1.1K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.1K
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
266
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
266
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
491
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
491
Dosage Regimens: Designs and Approaches
367
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
367


